Muraki Yo, Makita Yukimasa, Yamasaki Midori, Amano Yuichiro, Matsuo Takanori
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1 Muraokahigashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan.
Biochem Biophys Res Commun. 2017 May 6;486(3):632-638. doi: 10.1016/j.bbrc.2017.03.072. Epub 2017 Mar 18.
Endoplasmic reticulum (ER) stress caused by accumulation of misfolded proteins is observed in several kinds of diseases. Since ER stress is reported to be involved in the progression of non-alcoholic steatohepatitis (NASH), highly sensitive and simple measurement methods are required for research into developing novel therapy for NASH. To investigate the involvement of ER stress in NASH pathogenesis in a mouse model, an assay for liver ER stress was developed using ER stress activated indicator-luciferase (ERAI-Luc) mice. To establish the assay method for detection of ER stress in the liver, tunicamycin (TM) (0.3 mg/kg i. p.) was administered to ERAI-Luc mice, and the luciferase activity was measured in ex vivo and in vivo. To evaluate ER stress in the NASH model, ERAI-Luc mice were fed a modified choline-deficient l-amino acid-defined (mCDAA) diet for 14 weeks. After measurement of ER stress by luminescence imaging, levels of liver lipids and pro-fibrotic and pro-inflammatory gene expression were measured as NASH-related indexes. In non-invasive whole-body imaging, TM elevated luciferase activity in the liver, induced by activation of ER stress. The highest luminescence in the liver was confirmed by ex vivo imaging of isolated tissues. In parallel with progression of NASH, elevated luminescence induced by ER stress in liver was observed in mCDAA diet-fed ERAI-Luc mice. Luciferase activity was significantly and positively correlated to levels of triglyceride and free cholesterol in the liver, as well as to the mRNA expression of type 1 collagen α1 chain and tumor necrosis factor α. These data indicated that the use of ERAI-Luc mice was effective in the detection of ER stress in the liver. Moreover, the NASH model using ERAI-Luc mice can be a useful tool to clarify the role of ER stress in pathogenesis of NASH and to evaluate effects of drugs targeted against ER stress.
在多种疾病中都观察到了由错误折叠蛋白积累引起的内质网(ER)应激。由于据报道ER应激与非酒精性脂肪性肝炎(NASH)的进展有关,因此对于开发NASH新疗法的研究需要高度灵敏且简单的测量方法。为了在小鼠模型中研究ER应激在NASH发病机制中的作用,利用ER应激激活指示剂 - 荧光素酶(ERAI-Luc)小鼠开发了一种肝脏ER应激检测方法。为了建立检测肝脏中ER应激的方法,给ERAI-Luc小鼠腹腔注射衣霉素(TM)(0.3 mg/kg),并在体外和体内测量荧光素酶活性。为了评估NASH模型中的ER应激,给ERAI-Luc小鼠喂食改良的胆碱缺乏l-氨基酸定义(mCDAA)饮食14周。通过发光成像测量ER应激后,测量肝脏脂质水平以及促纤维化和促炎基因表达作为NASH相关指标。在非侵入性全身成像中,TM通过激活ER应激提高了肝脏中的荧光素酶活性。通过离体组织的体外成像证实了肝脏中的最高发光。与NASH的进展并行,在喂食mCDAA饮食的ERAI-Luc小鼠中观察到肝脏中由ER应激诱导的发光升高。荧光素酶活性与肝脏中甘油三酯和游离胆固醇水平以及I型胶原α1链和肿瘤坏死因子α的mRNA表达显著正相关。这些数据表明,使用ERAI-Luc小鼠可有效检测肝脏中的ER应激。此外,使用ERAI-Luc小鼠的NASH模型可以成为阐明ER应激在NASH发病机制中的作用以及评估针对ER应激的药物效果的有用工具。